I read your article, “Longevity Is Being Democratized,” with great interest.
Your distinction between Longevity Biotechnology and Longevity Medicine particularly resonated with me. As you describe it, Longevity Medicine is about what we can do today—using diagnostics, biomarker assessment, behavioral and metabolic interventions, personalized guidance, and prevention to improve peakspan, healthspan, and lifespan.
Your description of the Ping An initiative was especially compelling. I was particularly struck by your emphasis on its architecture—not a single product or intervention, but an integrated system combining preventive defenses, interventions addressing behavior, body, and mind, and multiple channels of healthcare delivery.
This is remarkably close to the philosophy behind a project I have been developing called Plantica—but with one important extension.
What if the principles of Longevity Medicine were incorporated not only into healthcare delivery, but into the design of the community in which people actually live?
Plantica is being conceived as what we believe could become the first purpose-designed Longevity Community: a residential community planned from the ground up around the principles that promote longer, healthier, and more functional lives.
The idea is that longevity should not depend solely on what happens during a medical consultation. The physical environment, nutrition, movement, social connection, psychological well-being, prevention, early detection, access to healthcare, and intelligent use of technology can all be deliberately incorporated into the architecture and daily functioning of a community.
In other words, rather than asking people to periodically enter a longevity clinic, Plantica asks whether we can create a longevity environment in which many of the principles of Longevity Medicine become part of everyday life.
Your broader observation that longevity is evolving from a niche interest into infrastructure struck me as particularly important. I believe that one of the next logical steps may be to translate this thinking into the places where people actually spend most of their lives.
We are now entering the architectural design stage of Plantica, which made the timing of your article particularly meaningful to me.
I would be delighted to share the concept with you and hear your perspective. Given your work at the intersection of longevity science, AI, biotechnology, and Longevity Medicine, I believe your insights could be extremely valuable as we explore what a genuinely purpose-designed longevity community should look like.
If the concept interests you, I would be very happy to arrange a brief conversation at your convenience.
Really enjoyed this perspective. Longevity has definitely started moving beyond the “exclusive wellness” space, and it’s interesting to see how much more accessible the conversation around it is becoming.
I do think there’s one important piece to this though , making information and tools accessible is great, but having more data doesn’t necessarily mean people will make better health decisions. Being able to actually understand that data and turn it into something useful for your own health is where I think the bigger opportunity lies. And honestly, that’s where AI could make a pretty meaningful difference.
Very true about the difference between longevity biotechnology and longevity medicine. If I’m reading the Ping An example correctly, the next big challenge may be getting existing interventions in front of people easily and cheaply enough to actually change behavior. If that delivery bottleneck improves, would evidence triage become the next one?
Dear Dr. Zhavoronkov,
I read your article, “Longevity Is Being Democratized,” with great interest.
Your distinction between Longevity Biotechnology and Longevity Medicine particularly resonated with me. As you describe it, Longevity Medicine is about what we can do today—using diagnostics, biomarker assessment, behavioral and metabolic interventions, personalized guidance, and prevention to improve peakspan, healthspan, and lifespan.
Your description of the Ping An initiative was especially compelling. I was particularly struck by your emphasis on its architecture—not a single product or intervention, but an integrated system combining preventive defenses, interventions addressing behavior, body, and mind, and multiple channels of healthcare delivery.
This is remarkably close to the philosophy behind a project I have been developing called Plantica—but with one important extension.
What if the principles of Longevity Medicine were incorporated not only into healthcare delivery, but into the design of the community in which people actually live?
Plantica is being conceived as what we believe could become the first purpose-designed Longevity Community: a residential community planned from the ground up around the principles that promote longer, healthier, and more functional lives.
The idea is that longevity should not depend solely on what happens during a medical consultation. The physical environment, nutrition, movement, social connection, psychological well-being, prevention, early detection, access to healthcare, and intelligent use of technology can all be deliberately incorporated into the architecture and daily functioning of a community.
In other words, rather than asking people to periodically enter a longevity clinic, Plantica asks whether we can create a longevity environment in which many of the principles of Longevity Medicine become part of everyday life.
Your broader observation that longevity is evolving from a niche interest into infrastructure struck me as particularly important. I believe that one of the next logical steps may be to translate this thinking into the places where people actually spend most of their lives.
We are now entering the architectural design stage of Plantica, which made the timing of your article particularly meaningful to me.
I would be delighted to share the concept with you and hear your perspective. Given your work at the intersection of longevity science, AI, biotechnology, and Longevity Medicine, I believe your insights could be extremely valuable as we explore what a genuinely purpose-designed longevity community should look like.
If the concept interests you, I would be very happy to arrange a brief conversation at your convenience.
Warm regards,
Dr. Ze'ev Gross
Family Physician
Founder, Plantica
Edmonton, Canada
Scaling access to longevity services is not necessarily the same as democratizing health.
Really enjoyed this perspective. Longevity has definitely started moving beyond the “exclusive wellness” space, and it’s interesting to see how much more accessible the conversation around it is becoming.
I do think there’s one important piece to this though , making information and tools accessible is great, but having more data doesn’t necessarily mean people will make better health decisions. Being able to actually understand that data and turn it into something useful for your own health is where I think the bigger opportunity lies. And honestly, that’s where AI could make a pretty meaningful difference.
Longevity Medicine-Longevity Biotechnology-Third Longevity Overlapping working on it
Very true about the difference between longevity biotechnology and longevity medicine. If I’m reading the Ping An example correctly, the next big challenge may be getting existing interventions in front of people easily and cheaply enough to actually change behavior. If that delivery bottleneck improves, would evidence triage become the next one?